Pacific Biosciences of California
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $39,007 | $37,178 | $44,645 | $38,441 |
Gross Profit | 12,638 | 12,841 | 16,748 | 15,068 |
EBITDA | -38,052 | -5,766 | -33,780 | -31,480 |
EBIT | -42,573 | -9,831 | -38,429 | -35,878 |
Net Income | -44,741 | -8,275 | -40,371 | -38,000 |
Net Change In Cash | 39,007 | 37,178 | 44,645 | 38,441 |
Free Cash Flow | -84,872 | -47,734 | -19,930 | -18,621 |
Cash | 61,003 | 56,293 | 63,707 | 56,467 |
Basic Shares | 310,655 | 305,819 | 301,907 | 300,844 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $160,005 | $154,014 | $200,521 | $128,304 |
Gross Profit | 50,674 | 37,282 | 52,780 | 49,035 |
EBITDA | -34,197 | -242,772 | -271,125 | -282,240 |
EBIT | -539,104 | -296,123 | -303,816 | -299,558 |
Net Income | -546,376 | -309,851 | -306,735 | -314,248 |
Net Change In Cash | 160,005 | 154,014 | 200,521 | 128,304 |
Free Cash Flow | -113,923 | -212,246 | -275,391 | -280,140 |
Cash | 63,707 | 55,370 | 179,911 | 325,089 |
Basic Shares | 299,959 | 288,366 | 253,629 | 224,550 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.14 |
2026-03-31 | -$0.12 |
2025-12-31 | -$0.12 |
2025-09-30 | -$0.12 |